Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance.
Although polyneuropathies associated with IgM and IgG monoclonal gammopathies have been well described, polyneuropathy with IgA monoclonal gammopathy of undetermined significance (MGUS) is less commonly seen and has not been well studied. We reviewed the clinical and electrodiagnostic features of 5 such patients, and the sural nerve biopsy findings in 4 of them. One patient was diabetic, while 4 were free of other diagnoses commonly associated with neuropathy. Clinical presentations were varied. Electrodiagnostic and histological studies ranged from primary demyelination to primary axon loss to a mixed axonal/demyelinating picture. Three patients who were treated appeared to respond to prednisone or intravenous gamma globulin, despite clear clinical, electrodiagnostic, and histological differences. We conclude that the polyneuropathy associated with IgA MGUS is heterogeneous, similar to that in IgM and IgG MGUS. A trial of immunomodulating therapy appears to be warranted in such patients if the neuropathy is sufficiently severe.
Department of Neurology, University of Michigan, Ann Arbor.
Z
Z
Simmons
M B
MB
Bromberg
E L
EL
Feldman
M
M
Blaivas
D000328:Adult; D000368:Aged; D004576:Electromyography; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis*; D008297:Male; D009431:Neural Conduction / Q000502:physiology; D010265:Paraproteinemias / Q000150:complications / Q000503:physiopathology*; D010523:Peripheral Nervous System Diseases / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology; D013497:Sural Nerve / Q000473:pathology
D007070:Immunoglobulin A